NCT06444412
- Conditions
- WHO Grade 3 Glioma, WHO Grade 4 Glioma
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
WHO Grade 3 Glioma
Explore clinical trials studying WHO Grade 3 Glioma. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
WHO Grade 3 Glioma trial results
NCT06964737
- Conditions
- Glioma, Neoplasms, Neoplasms by Histologic Type, +11 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Not Yet Recruiting
Study of Relatlimab and Nivolumab (Opdualag) in Replication Repair Deficient HGG and DIPG
NCT07644312
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +19 more
- Locations
-
Not specified
Not Yet Recruiting
Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)
NCT07206849
- Conditions
- Brain Diseases, Brain Neoplasms, Brain Stem Neoplasms, +21 more
- Locations
-
Not specified
NCT02323880
- Conditions
- Astrocytoma, Brain Diseases, Brain Neoplasms, +29 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Children's Hospital Los Angeles Los Angeles, California, United States
- Children's Hospital of Orange County Orange, California, United States
- UCSF Medical Center-Mission Bay San Francisco, California, United States
Active, Not Recruiting
Proton Beam or Intensity-Modulated Radiation Therapy in Preserving Brain Function in Patients With IDH Mutant Grade II or III Glioma
NCT03180502
- Conditions
- Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, +13 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Boca Raton Regional Hospital Boca Raton, Florida, United States
- Miami Cancer Institute Miami, Florida, United States
- Emory Proton Therapy Center Atlanta, Georgia, United States
Active, Not Recruiting
Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma
NCT03919071
- Conditions
- Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Anaplastic Ganglioglioma, +14 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Banner Children's at Desert Mesa, Arizona, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
Active, Not Recruiting
Olaparib in Treating Patients With Advanced Glioma, Cholangiocarcinoma, or Solid Tumors With IDH1 or IDH2 Mutations
NCT03212274
- Conditions
- Adenocarcinoma, Advanced Malignant Solid Neoplasm, Astrocytoma, +16 more
- Locations
-
- UC Irvine Health Cancer Center-Newport Costa Mesa, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States